CLASSYS Inc. (KOSDAQ:214150)
South Korea · Delayed Price · Currency is KRW 32,050
+1,050 (3.39%)
Sep 11, 2026, 3:30 PM KST
CLASSYS Revenue
CLASSYS had revenue of 105.52B KRW in the quarter ending June 30, 2026, with 26.69% growth. This brings the company's revenue in the last twelve months to 369.11B, up 25.46% year-over-year. In the year 2025, CLASSYS had annual revenue of 336.82B with 38.64% growth.
Revenue (ttm)
369.11B
Revenue Growth
+25.46%
P/S Ratio
5.66
Revenue / Employee
936.84M
Employees
394
Market Cap
2.09T
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 336.82B | 93.88B | 38.64% |
| Dec 31, 2024 | 242.94B | 62.82B | 34.87% |
| Dec 31, 2023 | 180.12B | 38.32B | 27.02% |
| Dec 31, 2022 | 141.80B | 41.21B | 40.96% |
| Dec 31, 2021 | 100.60B | 24.14B | 31.57% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| SD Biosensor | 738.76B |
| Seegene | 509.27B |
| i-SENS | 326.19B |
| InBody Co.,Ltd | 263.89B |
| T&L Co., Ltd. | 175.16B |
| WON TECH | 167.35B |
| BioNote | 126.41B |
| L&C BIO Co.,LTD | 116.30B |